...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith down 50% this morning in US

Sort of.  736 shares traded at 15 cents. Doesn't mean much.  Most of the volume was at 29 and 30 cents where I suspect it will be back to soon.

Share
New Message
Please login to post a reply